The brain in diabetes: molecular changes in neurons and their implications for end-organ damage

Donnelly, 2000, ABC of arterial and venous disease: vascular complications of diabetes, BMJ, 320, 1062, 10.1136/bmj.320.7241.1062 Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a Dheen, 1994, Arginine vasopressin and oxytocin-like immunoreactive neurons in the hypothalamic paraventricular and supraoptic nuclei of streptozotocin- induced diabetic rats, Arch Histol Cytol, 57, 461, 10.1679/aohc.57.461 Serino, 1998, Upregulation of hypothalamic nitric oxide synthase gene expression in streptozotocin-induced diabetic rats, Diabetologia, 41, 640, 10.1007/s001250050962 Chakfe, 2000, Excitatory peptides and osmotic pressure modulate mechanosensitive cation channels in concert, Nat Neurosci, 3, 572, 10.1038/75744 Voisin, 2002, Integration of sodium and osmosensory signals in vasopressin neurons, Trends Neurosci, 25, 199, 10.1016/S0166-2236(02)02142-2 Andrew, 1983, Burst discharge in mammalian neuroendocrine cells involves an intrinsic regenerative mechanism, Science, 221, 1050, 10.1126/science.6879204 Sperlagh, 1999, Local regulation of vasopressin and oxytocin secretion by extracellular ATP in the isolated posterior lobe of the rat hypophysis, J Endocrinol, 160, 343, 10.1677/joe.0.1600343 Luo, 2002, Neuronal and glial response in the rat hypothalamus-neurohypophysis complex with streptozotocin-induced diabetes, Brain Res, 925, 42, 10.1016/S0006-8993(01)03258-9 Goldin, 2000, Nomenclature of voltage-gated sodium channels, Neuron, 28, 365, 10.1016/S0896-6273(00)00116-1 Catterall, 2000, From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels, Neuron, 26, 13, 10.1016/S0896-6273(00)81133-2 Tanaka, 1999, Molecular and functional remodeling of electrogenic membrane of hypothalamic neurons in response to changes in their input, Proc Natl Acad Sci USA, 96, 1088, 10.1073/pnas.96.3.1088 Klein, 2002, Sodium channel expression in hypothalamic osmosensitive neurons in experimental diabetes, NeuroReport, 13, 1481, 10.1097/00001756-200208070-00027 Crill, 1996, Persistent sodium current in mammalian central neurons, Annu Rev Physiol, 58, 349, 10.1146/annurev.ph.58.030196.002025 Parri, 1998, Sodium current in rat and cat thalamocortical neurons: role of a non-inactivating component in tonic and burst firing, J Neurosci, 18, 854, 10.1523/JNEUROSCI.18-03-00854.1998 Taddese, 2002, Subthreshold sodium current from rapidly inactivating sodium channels drives spontaneous firing of tuberomammillary neurons, Neuron, 33, 587, 10.1016/S0896-6273(02)00574-3 Scroggs, 1992, Multiple Ca2+ currents elicited by action potential waveforms in acutely isolated adult rat dorsal root ganglion neurons, J Neurosci, 12, 1789, 10.1523/JNEUROSCI.12-05-01789.1992 Zheng, 2002, Neuronal expression of fos protein in the forebrain of diabetic rats, Brain Res, 956, 268, 10.1016/S0006-8993(02)03550-3 Ahloulay, 1999, Vasopressin and urinary concentrating activity in diabetes mellitus, Diabetes Metab, 25, 213 Bouby, 1999, Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats, Life Sci, 65, 991, 10.1016/S0024-3205(99)00330-6 Laycock, 1998, From vasopressin receptor to water channel: intracellular traffic, constraint and by-pass, J Endocrinol, 159, 361, 10.1677/joe.0.1590361 Bankir, 2001, Vasopressin and diabetes mellitus, Nephron, 87, 8, 10.1159/000045879 Bardoux, 1999, Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats, Proc Natl Acad Sci USA, 96, 10397, 10.1073/pnas.96.18.10397 Dheen, 1994, Ultrastructural changes in the hypothalamic supraoptic nucleus of the streptozotocin-induced diabetic rat, J Anat, 184, 615 Coyle, 1993, Oxidative stress, glutamate, and neurodegenerative disorders, Science, 262, 689, 10.1126/science.7901908 Dawson, 1991, Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures, Proc Natl Acad Sci USA, 88, 6368, 10.1073/pnas.88.14.6368 Reske-Nielsen, 1963, Diabetic encephalopathy: diffuse and focal lesions of the brain in long-term diabetes, Acta Neurol Scand, 39, 273, 10.1111/j.1600-0404.1963.tb01844.x Reske-Nielsen, 1965, Pathological changes in the central and peripheral nervous systems of young long-term diabetics, 1: diabetic encephalopathy, Diabetologia, 1, 233, 10.1007/BF01257917 Biessels, 1994, Cerebral function in diabetes mellitus, Diabetologia, 37, 643, 10.1007/BF00417687 Biessels, 2002, Ageing and diabetes: implications for brain function, Eur J Pharmacol, 441, 1, 10.1016/S0014-2999(02)01486-3 Gispen, 2000, Cognition and synaptic plasticity in diabetes mellitus, Trends Neurosci, 23, 542, 10.1016/S0166-2236(00)01656-8 Ryan, 1988, Neurobehavioral complications of type I diabetes: examination of possible risk factors, Diabetes Care, 11, 86, 10.2337/diacare.11.1.86 Flood, 1990, Characteristics of learning and memory in streptozocin-induced diabetic mice, Diabetes, 39, 1391, 10.2337/diab.39.11.1391 Popovic, 2001, Learning and memory in streptozotocin-induced diabetic rats in a novel spatial/object discrimination task, Behav Brain Res, 122, 201, 10.1016/S0166-4328(01)00186-3 Ferguson, 2003, Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia, Diabetes, 52, 149, 10.2337/diabetes.52.1.149 Rennick, 1968, Retinopathy as an indicator of cognitive-perceptual-motor impairment in diabetic adults (summary), Proceedings of the 76th Annual Convention of the American Psychology Association, 473 Holmes, 1986, Neuropsychological profiles in men with insulin-dependent diabetes, J Consult Clin Psychol, 54, 386, 10.1037/0022-006X.54.3.386 Biessels, 1996, Place learning and hippocampal synaptic plasticity in streptozotocin- induced diabetic rats, Diabetes, 45, 1259, 10.2337/diab.45.9.1259 Kamal, 1999, Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression, Neuroscience, 90, 737, 10.1016/S0306-4522(98)00485-0 Gardoni, 2002, Effects of streptozotocin-diabetes on the hippocampal NMDA receptor complex in rats, J Neurochem, 80, 438, 10.1046/j.0022-3042.2001.00713.x Di Luca, 1999, NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats, Diabetologia, 42, 693, 10.1007/s001250051217 Candy, 2000, Neuronal excitability and conduction velocity changes in hippocampal slices from streptozotocin-treated diabetic rats, Brain Res, 863, 298, 10.1016/S0006-8993(00)02171-5 Magarinos, 2000, Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress, Proc Natl Acad Sci USA, 97, 11056, 10.1073/pnas.97.20.11056 Levy, 1994, Diabetes mellitus: a disease of abnormal cellular calcium metabolism?, Am J Med, 96, 260, 10.1016/0002-9343(94)90152-X Greene, 1983, Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation, J Clin Invest, 72, 1058, 10.1172/JCI111030 Lowery, 1990, Distribution of elements and water in peripheral nerve of streptozocin-induced diabetic rats, Diabetes, 39, 1498, 10.2337/diab.39.12.1498 Li, 2002, Hippocampal neuronal apoptosis in type 1 diabetes, Brain Res, 946, 221, 10.1016/S0006-8993(02)02887-1 Russell, 1999, Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose, Horm Metab Res, 31, 90, 10.1055/s-2007-978704 Baydas, 2003, Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E, Eur J Pharmacol, 462, 67, 10.1016/S0014-2999(03)01294-9 Saravia, 2002, Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice, Brain Res, 957, 345, 10.1016/S0006-8993(02)03675-2 Nagamatsu, 1992, Glucose transporter expression in brain. cDNA sequence of mouse GLUT3, the brain facilitative glucose transporter isoform, and identification of sites of expression by in situ hybridization, J Biol Chem, 267, 467, 10.1016/S0021-9258(18)48518-3 Nagamatsu, 1993, Neuron-specific glucose transporter (NSGT): CNS distribution of GLUT3 rat glucose transporter (RGT3) in rat central neurons, FEBS Lett, 334, 289, 10.1016/0014-5793(93)80697-S McCall, 1994, Immunohistochemical localization of the neuron-specific glucose transporter (GLUT3) to neuropil in adult rat brain, Brain Res, 659, 292, 10.1016/0006-8993(94)90896-6 Reagan, 1999, Regulation of GLUT-3 glucose transporter in the hippocampus of diabetic rats subjected to stress, Am J Physiol, 276, E879 McCall, 1992, The impact of diabetes on the CNS, Diabetes, 41, 557, 10.2337/diab.41.5.557 Mooradian, 1988, Diabetic complications of the central nervous system, Endocr Rev, 9, 346, 10.1210/edrv-9-3-346 Reagan, 2002, Diabetes, but not stress, reduces neuronal nitric oxide synthase expression in rat hippocampus: implications for hippocampal synaptic plasticity, NeuroReport, 13, 1801, 10.1097/00001756-200210070-00022 Holscher, 1997, Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity, Trends Neurosci, 20, 298, 10.1016/S0166-2236(97)01065-5 Biessels, 2002, Neuronal Ca(2+) disregulation in diabetes mellitus, Eur J Pharmacol, 447, 201, 10.1016/S0014-2999(02)01844-7 Li, 2002, C-peptide prevents hippocampal apoptosis in type 1 diabetes, Int J Exp Diabetes Res, 3, 241, 10.1080/15604280214936